Gabriela Funez-dePagnier

Statistics

Publications

Citations

198

H-Index

Active since

2020

Affiliations

Weill Cornell Medicine(Current)

Cornell University

New York Hospital Queens

NewYork–Presbyterian Hospital

Presbyterian Hospital

Gabriela Funez-dePagnier is an author at Weill Cornell Medicine specializing in gastrointestinal inflammation, inflammation, and inflammatory bowel disease.

Publications per year

2020–2024

Publications

Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease

Dana J. Lukin, Anand Kumar, Kaveh Hajifathalian et al. · Gastroenterology · 2020 · 107 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +13

Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses

Julia W. Angkeow, Daniel R. Monaco, Athena Chen et al. · Immunity · 2022 · 41 citations · Full text

Life Sciences, Immunology, Molecular Biology +15

The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis

Svetlana Lima, Sílvia Pires, Amanda Rupert et al. · Cell Reports Medicine · 2024 · 36 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

No Durable Impact of COVID-19 on Intestinal Disease Activity in Subjects With IBD

Dana J. Lukin, Gabriela Funez-dePagnier, Svetlana Lima et al. · Clinical Gastroenterology and Hepatology · 2021 · 14 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

1–4 of 4